Clinical trial • Phase III • Oncology
Ceralasertib for Advanced solid tumor
Phase III trial of Ceralasertib for Advanced solid tumor. 20 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumor
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 28-01-2025
Recruitment
- Recruitment Window Months
- 5
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 20
Spain
- Earliest CTIS Part Ii Submission Date
- 14-04-2025
- Latest Decision Or Authorization Date
- 13-05-2025
- Processing Time Days
- 29
- Number Of Sites
- 3
- Number Of Participants
- 18
Sites
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- #7002:Medical Oncology
- Contact Person Name
- Manuel Pedregal Trujillo
- Contact Person Email
- Manuel.pedregal@startmadrid.com
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- #7001:Medical Oncology
- Contact Person Name
- Irene Moreno Candilejo
- Contact Person Email
- irene.moreno@startmadrid.com
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- #7003;Medical Oncology
- Contact Person Name
- Tatiana Carolina Hernández Guerrero
- Contact Person Email
- tatiana.hernandez@start-barcelona.com
Sponsor
Primary sponsor
- Full Name
- AstraZeneca AB
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Sweden
Investigational products
- Investigational Product Name
- Ceralasertib
- Active Substance
- Ceralasertib
Related trials
Other published trials that may interest you.